News Breaks |
|
|
| September 27, 2012 |
| 07:11 EDT |  | SNTS | Santarus says CORE I clinical study shows statistical significance
Santarus announced that results from its CORE I clinical study, one of two of the company’s pivotal Phase III clinical studies with UCERIS in ulcerative colitis, have been published online in the journal Gastroenterology. The results from CORE I indicate that the investigational drug UCERIS 9 mg had a statistically significant benefit over placebo in the primary endpoint of combined clinical and endoscopic remission at week 8 among patients with active, mild to moderate ulcerative colitis. The FDA is currently reviewing the company’s New Drug Application for UCERIS for the induction of remission in patients with active, mild to moderate ulcerative colitis with a target action date of January 16, 2013. |
|
|
News For SNTS From The Last 14 Days Check below for free stories on SNTS the last two weeks. |
|
|
| May 17, 2013 |
| 10:36 EDT |  | SNTS | Leerink's major/specialty pharma analyst holds analyst/Industry conference call
 Subscribe for More Information |
|
| May 10, 2013 |
| 09:06 EDT |  | SNTS | Santarus 4.25M share Spot Secondary priced at $18.25
Subscribe for More Information |
|
| 09:00 EDT |  | SNTS | Santarus falls 7.3%
Subscribe for More Information |
|
| May 9, 2013 |
| 16:02 EDT | | SNTS | Santarus files to sell common stock for Cosmo Technologies, no amount given
Subscribe for More Information |
|
| May 7, 2013 |
| 09:17 EDT | | SNTS | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 09:00 EDT | | SNTS | Santarus rises 10.2%
Subscribe for More Information |
|
| May 6, 2013 |
| 18:56 EDT | | SNTS | On The Fly: After Hours Movers
UP AFTER EARNINGS: MercadoLibre (MELI), up 10%... Santarus (SNTS), up 11.2%... BroadSoft (BSFT), up 8%. ALSO HIGHER: First Solar (FSLR), up 1.2% after reporting first quarter earnings, affirming its full-year guidance, and announcing plans to cut 150 employees this quarter. DOWN AFTER EARNINGS: Ruckus Wireless (RKUS), down 17%... Forest Oil (FST), down 4.2%. ALSO LOWER: Generac (GNRC), down 3.2% after filing to sell 9M shares of common stock for holders. |
|
| 16:26 EDT |  | SNTS | Santarus raises FY13 adjusted EPS view to $1.03-$1.15 from prior 92c-$1.00
Subscribe for More Information |
|
| 16:24 EDT | | SNTS | Santarus raises FY13 revenue view to about $330M-$340M from prior $320M-$325M
Subscribe for More Information |
|
| 16:23 EDT | | SNTS | Santarus raises FY13 EPS view to 72c-81c from 63c-68c, consensus 76c
Subscribe for More Information |
| |
| 16:22 EDT | | SNTS | Santarus reports Q1 adjusted EPS 32c, consensus 14c
Subscribe for More Information |
|
| 16:02 EDT | | SNTS | Santarus trading halted, pending news
Subscribe for More Information |
|
|
|
|
|
